Humana (HUM) is a publicly traded Healthcare sector company. As of July 4, 2026, HUM trades at $396.75 with a market cap of $47.63B and a P/E ratio of 42.25. HUM moved -2.55% today. Year to date, HUM is +54.90%; over the trailing twelve months it is +62.74%. Its 52-week range spans $163.11 to $415.00. Analyst consensus is neutral with an average price target of $294.56. Rallies surfaces HUM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for HUM combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $396.75 |
| Market Cap | $47.63B |
| P/E Ratio | 42.25 |
| EPS | $9.39 |
| Dividend Yield | 0.89% |
| 52-Week High | $415.00 |
| 52-Week Low | $163.11 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $137.20B |
| Net Income | $1.15B |
| Gross Margin | 0.00% |
19 analysts cover HUM: 0 strong buy, 6 buy, 11 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $294.56.